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The glucuronidatron of thyroid hormone by UDP-glucuronyltransferases (UGTs) stably transfected m Chmese hamster V79 lung fibroblasts was 
investigated. Human bilirubm UGT (HP3) and phenol UGT (HP4) both catalysed the glucuromdatton of T4 and rT3, whereas glucuronidatton 
of T3 was not significant. rT3 was the preferred substrate for both isoenzymes, glucuromdatton rates bemg 1.6- and 6.4.times higher than 
conjugatton of T4 by HP3 and HP4 clones. respectively. This 1s the first tdenttficatron of thyroid hormone as potential alternative endogenous 
substrate for bthrubin UGT. 
Thyroid hormone: lodothyronine: Glucuronidation; Biiirubm: Phenol; UDP-ghrcuronyltransferase: Human liver 
1. INTRODUCTION 
Deiodination and conjugation are the principal meta- 
bolic pathways for thyroid hormone [l-3]. Thyroxine 
(T4) is the main secretory product of the thyroid but has 
little biological activity. The most active form of thyroid 
hormone, 3.3’,5-triiodothyronine (T3), is largely pro- 
duced by outer ring deiodination of T4 in peripheral 
tissue, while the inactive metabolite, 3,3’,5’-triiodothy- 
ronine (reverse T3, rT3), is generated by inner ring 
deiodination of T4 [1,2]. Glucuronidation is a major 
pathway for biotransformation of the iodothyronines 
[2.3]. and the conjugates are subsequently excreted in 
bile. 
Studies of rat strains with genetic defects in UGT 
isoenzymes have suggested that T4 and rT3 are primar- 
ily conjugated by both phenol and bilirubin UGTs and 
T3 by androsterone UGT [4-61. Induction of hepatic 
microsomal phenol and bilirubin UGTs in rats by 3- 
methylcholanthrene (MC) and phenoxyisobutyrate (fi- 
brate) compounds, respectively, led to an increase in the 
rate of glucuronidation of T4, also suggesting that this 
iodothyronine is a substrate for the two UGTs [5,7,8]. 
Further work has also correlated the induction of he- 
patic UGTs by xenobiotics with the reduction in serum 
thyroid hormone levels [9-l 11. 
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Chinese hamster V79 lung fibroblasts were trdnsfected with full- 
length HPl, HP3 or HP4 cDNA ligated mto the eukaryotic expression 
vector pcDNAlneo as described m detail elsewhere [12-151. As con- 
trols, non-trdnsfected V79 cells were used. Transfected and control 
V79 cells were grown to 70% confluence, harvested, and washed twice 
wrth PBS. Cells were disrupted by hypotonic shock in water and 
repeated freezethawmg, and the homogenates were stored at -80°C 
until further analysis. Protem content was determined with the BCA 
protein assay reagent (Pierce. Oud Betjerland, The Netherlands) using 
BSA as the standard. Human liver mtcrosomes were obtained as 
previously described [16]. 
*Present trddress: Margaret Fischer-Bosch Instttut fur Kluusche Phar- Glucuronidation of todothyronmes by human liver microsomes or 
makologte, Auerbachstrasse 112. 7000 Stuttgart 50, Germany, cell homogenates was analyzed as previously described [4-71 Briefly. 
Little is known about glucuronidation of thyroid 
hormone in human liver or the possible changes which 
may be caused by chronic treatment with therapeutic 
drugs, which are inducers of UGTs. Therefore, in this 
study we have investigated the potential glucuronida- 
tion of T4. T3 and rT3 by human liver microsomes, as 
well as human phenol and bilirubin UGTs, produced by 
cloning cDNAs and stable expression in heterologous 
V79 cells, which do not exhibit endogenous background 
UGT activities [ 12-151. 
2. MATERIALS AND METHODS 
[3’,5’-‘:‘I]T4. [3’-““IIT and [3’.5’-“‘I]rT3 were obtamed from 
Amersham (Amersham, UK); T4 and T3 from Stgma (St. Louis. MO, 
USA), rT3 from Henning GmbH (Berlm. Germany): UDP-glucuromc 
acid (UDPGA) from Boehrmger-Mannheim (Almere, The Nether- 
lands): and Sephadek LH-20 from Pharmacta (Woerden, The Nether- 
lands). 
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1 PM T4, T3, or rT3, and eO.1 PCi of the “51-labeled substrate were 
incubated in triplicate for 60 min at 37°C wtth 1 mg enzyme protein/ml 
and 5 mM UDPGA in 200 ~175 mM Tris-HCI (pH 7.8) and 7.5 mM 
MgCl?. Control incubations were done in the absence of UDPGA. 
Reactions were terminated by addition of 200 yl ice-cold methanol 
After centrifugatton, supernatants were analyzed for glucuronide for- 
mation on Sephadex LH-20 [4]. 
3. RESULTS 
The present experiments have been conducted with 
three members of the UGTl subfamily, i.e. HP1 which 
glucuronidates planar phenols such as 1 -naphthol, HP3 
which glucuronidates bilirubin, and HP4 which glucu- 
ronidates bulky phenols such as 2,6-diisopropylphenol 
[12-151. The UGT activities of homogenates of V79 
cells stably transfected with HPl, HP3 or HP4 cDNA, 
expressed per mg protein, are similar to the rates of 
glucuronidation of 1 -naphthol, bilirubin and 2,6-diiso- 
propylphenol, respectively, by human liver microsomes 
[12-151. Another member of the UGTl subfamily re- 
cently cloned and expressed in cell culture, HP2, also 
glucuronidates bilirubin [ 171, but has not yet been tested 
for iodothyronine UGT activity. 
Human liver microsomes catalysed the glucuronida- 
tion of T4, T3 and rT3 at the rates shown in Fig. 1, 
representing 7% (T3, rT3) to 27% (T4) of the iodothy- 
ronine UGT activities determined previously in Wistar 
rat liver microsomes [6]. Glucuronidation of the differ- 
ent iodothyronines was undetectable in homogenates of 
non-transfected V79 cells, as well as in cells transfected 
with HP1 (not shown). Glucuronidation of T3 was also 
very low in homogenates of cells transfected with either 
HP3 or HP4 cDNA, however, these cells showed signif- 
icant UGT activity for T4 and rT3 (Fig. 1). The HP3 
and in particular the HP4 isoenzyme showed a clear 
substrate preference for rT3, glucuronidation rates of 
which were 1.6- and 6.4-fold higher than with T4, re- 
spectively. 
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Fig. 1. UGT activities for T4, T3 and rT3 in human liver mtcrosomes 
and in homogenates of V79 cells stably transfected with HP3 or HP4 
cDNA. Results are the means + S.D. of 4 human hvers or of triplicate 
incubations with cell homogenates m a representattve experiment, 
4. DISCUSSION 
Glucuronidation is an important reaction for the met- 
abolic clearance of a variety of endogenous and ex- 
ogenous substances; it increases the water-solubility of 
these compounds and, thus, facilitates their biliary and 
urinary excretion [18,19]. The UGTs catalysing this re- 
action represent a family of homologous enzymes with 
broad and overlapping substrate specificity. They are 
located in the endoplasmic reticulum of different tis- 
sues. especially liver, and all use UDPGA as the glucu- 
ronic acid donor. Previous attempts to distinguish the 
different isoenzymes have been based on properties 
such as substrate specificity, ontogenic profiles and in- 
ducibility [18.19]. Recent progress in protein purifica- 
tion and cDNA cloning, however. have led to the eluci- 
dation of the structures of an increasing number of 
UGT isoenzymes [20]. 
Our findings fully support the hypothesis of the in- 
volvement of both phenol and bilirubin UGTs in the 
glucuronidation of T4 and rT3. Also in agreement with 
earlier work using rat liver microsomes [6] are the find- 
ings that rT3 is preferred over T4 as the substrate for 
these isoenzymes, in particular the phenol-glucu- 
ronidating UGT HP4. This is the first report of the 
identification of alternative endogenous substrates for 
bilirubin UGT. The insignificant glucuronidation of T3 
by both phenol UGT and bilirubin UGT is also in 
agreement with previous findings [6]; however, the ulti- 
mate proof that T3 glucuronidation is indeed catalysed 
by androsterone UGT must await the availability of 
transfected cells, expressing high levels of this isoen- 
zyme. Also, the possible contribution of the other biliru- 
bin-conjugating isoenzymes HP2 to the glucuronidation 
of thyroid hormone remains to be investigated. 
An exciting recent development has been the charac- 
terization in both humans and rats of the UGTl sub- 
family, which comprises the 2 bilirubin UGTs (HP2 and 
HP3), the 2 phenol UGTs (HP1 and HP4) and at least 
3 other isoenzymes, all encoded by a single gene [21]. 
Through differential splicing of the primary transcripts, 
the different mature mRNAs are produced, the se- 
quences of which consist of a common domain and a 
variable domain. These probably code for the C-termi- 
nal UDPGA-binding domain and the N-terminal sub- 
strate-binding domain of the protein, respectively [19- 
211. 
Although encoded by a single gene, the expression of 
the individual UGTl isoenzymes in rats and possibly in 
man is subject to different control mechanisms. Thus, 
the expression of the phenol-conjugating isoenzyme(s) 
is increased by MC-type inducers, while the expression 
of the bilirubin UGT(s) is stimulated among others by 
fibrate derivatives [18]. UGTl isoenzymes are also reg- 
ulated by thyroid hormone in rats; bilirubin UGT activ- 
ity decreases and phenol UGT increases in hyperthy- 
roidism, while the reverse is true in hypothyroidism [22]. 
359 
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Since iodothyronines share UGTs with other en- 
dogenous substrates, such as bilirubin and perhaps an- 
drosterone, it may not be surprising that the role of 
changes in these UGT activities in the regulation by 
thyroid hormone of its own metabolism is limited [23]. 
In summary, we have demonstrated that T4 and rT3. 
but not T3, are substrates for both human UGT isoen- 
zymes HP3 and HP4, which are known to glucuronidate 
bilirubin and bulky phenols, respectively. These results 
are in agreement with results in rats showing a parallel 
induction in UGT activities for bilirubin. T4 and rT3 
after treatment with fibrates [.5,7,8]. The increased glu- 
curonidation of 1 -naphthol. T4 and rT3 after treatment 
with MC-type inducers [4,&8], probably reflects the 
simultaneous induction of the rat homologs of HP1 and 
HP4. 
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